What is the appropriate propofol infusion dosage for pediatric patients undergoing surgery with inhalational anesthesia without a muscle relaxant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Propofol Infusion Dosage in Pediatric Surgery with Inhalational Anesthesia Without Relaxant

For pediatric patients undergoing surgery with inhalational anesthesia without muscle relaxants, use propofol maintenance infusion rates of 200-300 mcg/kg/min (12-18 mg/kg/h) initially, then reduce to 125-150 mcg/kg/min (7.5-9 mg/kg/h) after the first 30 minutes, supplemented with 60-70% nitrous oxide.

Maintenance Infusion Strategy

The FDA-approved dosing for pediatric maintenance anesthesia provides clear guidance 1:

  • Initial 30 minutes: Start at 200-300 mcg/kg/min immediately following induction
  • After 30 minutes: Reduce to 125-150 mcg/kg/min for the remainder of surgery
  • Co-administration: Use with 60-70% nitrous oxide in oxygen

Younger children require higher infusion rates than older pediatric patients within this range 1. This is supported by pharmacokinetic data showing children aged 3-11 years need approximately 15 mg/kg/h initially, decreasing stepwise to 9 mg/kg/h by 2-4 hours to maintain steady-state concentrations 2.

Age-Specific Considerations

Children have fundamentally different propofol pharmacokinetics than adults, requiring substantially higher weight-based infusion rates 2. The context-sensitive half-time in children is longer (10.4 minutes at 1 hour, rising to 19.6 minutes at 4 hours) compared to adults, explaining why simple size-based scaling from adult doses is inadequate 2.

Integration with Inhalational Anesthesia

When combining propofol with sevoflurane (without relaxants), the inhalational agent concentration significantly impacts propofol requirements 3:

  • At 3% end-tidal sevoflurane: approximately 1.5-2 mg/kg propofol provides excellent intubating conditions
  • At 4% end-tidal sevoflurane: propofol requirements decrease to approximately 0.5-1 mg/kg

Critical caveat: Even low-dose sevoflurane (0.35-0.45%) can dramatically suppress neurophysiological monitoring when combined with propofol in infants, particularly those under 6 months 4. If neuromonitoring is required, avoid inhalational agents or keep them below 0.5 MAC.

Titration Principles

The FDA label emphasizes that propofol should be titrated to clinical effect 1. During maintenance:

  • Monitor for signs of light anesthesia (movement, vital sign changes)
  • Adjust infusion rates rather than relying on boluses when possible
  • Avoid rapid boluses in pediatric patients as they increase risk of hypotension, apnea, and oxygen desaturation 1

Important Safety Considerations

Propofol infusion syndrome risk: While the FDA approves propofol for children ≥2 months for general anesthesia, exercise extreme caution with prolonged infusions (>4 hours) or high doses, especially in infants under 6 months 4. The French guidelines note that muscle relaxation actually improves intubation conditions and reduces adverse respiratory events in infants 5, suggesting that avoiding relaxants may not always be the safest approach in this age group.

Without muscle relaxants, ensure adequate depth of anesthesia before airway manipulation. The combination of propofol infusion with inhalational agents provides this depth, but requires careful titration to avoid excessive cardiovascular depression 1.

Practical Dosing Algorithm

  1. Induction: 2.5-3.5 mg/kg propofol (higher end for younger children) 1
  2. Immediate post-induction: Begin infusion at 200-300 mcg/kg/min with 60-70% N₂O
  3. First 30 minutes: Maintain 200-300 mcg/kg/min, titrate to clinical response
  4. After 30 minutes: Reduce to 125-150 mcg/kg/min
  5. Ongoing: Adjust based on surgical stimulation and patient response

Younger children (ages 2-5) typically need rates at the higher end of these ranges, while older children (ages 6-12) need lower rates within the specified ranges 1, 2.

References

Related Questions

What is the recommended dose for a continuous propofol infusion, including initiation and maintenance rates?
What is the recommended propofol infusion dosing regimen for pediatric patients, including induction bolus and maintenance infusion rates for procedural sedation and general anesthesia?
What volume of 1% propofol (10 mg/mL) should be administered for induction in a typical 70 kg adult?
In a 15-year-old patient weighing 71.5 kg in the emergency department, is a single intravenous push of 60 mg propofol appropriate for induction?
Can propofol be administered to a non-intubated patient?
What is the first investigation for a patient with suspected pheochromocytoma?
In a dengue patient with severe lethargy and peripheral oxygen saturation (SpO₂) dropping to 93% after urination, how can the patient be stimulated to become active and how can SpO₂ be increased when there is no pulmonary fluid accumulation?
In a 40‑year‑old patient with multiple low‑flow vascular malformations (hemangiomas) in the abdomen, gluteal region, chest, a resolved neck lesion, an interatrial septal aneurysm, a subcapsular splenic cyst, and a family history of cervical cancer, what diagnostic work‑up should be performed, including recommendations for genetic testing and specific imaging and laboratory studies?
What is the differential diagnosis and recommended next steps for a 39-year-old man with a low white blood cell count, elevated red blood cell count, hemoglobin, hematocrit, low platelet count, and increased mean platelet volume on a complete blood count?
What is the normal hemoglobin A1c range for a healthy 3-year-old female?
In a 17‑year‑old patient taking oxcarbazepine (Trileptal) for challenging behaviors who continues to have problematic behaviors, what medication should be added and what baseline laboratory studies should be ordered?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.